CNC Stock - Centene Corporation
Unlock GoAI Insights for CNC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B |
| Gross Profit | $16.83B | $17.32B | $16.66B | $14.20B | $15.22B |
| Gross Margin | 10.3% | 11.2% | 11.5% | 11.3% | 13.7% |
| Operating Income | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B |
| Net Income | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B |
| Net Margin | 2.0% | 1.8% | 0.8% | 1.1% | 1.6% |
| EPS | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 |
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 14th 2025 | Goldman | Initiation | Sell | $33 |
| July 28th 2025 | Cantor Fitzgerald | Downgrade | Neutral | $38 |
| July 23rd 2025 | Wells Fargo | Downgrade | Equal Weight | $30 |
| July 21st 2025 | TD Cowen | Downgrade | Hold | $33 |
| July 16th 2025 | BofA Securities | Downgrade | Underperform | $30 |
| July 10th 2025 | Morgan Stanley | Downgrade | Equal Weight | $33 |
| July 2nd 2025 | JP Morgan | Downgrade | Neutral | $48 |
| July 2nd 2025 | UBS | Downgrade | Neutral | $45 |
| June 9th 2025 | Morgan Stanley | Resumed | Overweight | $70 |
| June 2nd 2025 | Barclays | Downgrade | Equal Weight | $65 |
| April 8th 2025 | Jefferies | Upgrade | Hold | $64 |
| February 6th 2025 | Argus | Downgrade | Hold | - |
| December 17th 2024 | JP Morgan | Resumed | Overweight | $75← $80 |
| December 13th 2024 | UBS | Upgrade | Buy | $80← $79 |
| December 10th 2024 | Jefferies | Downgrade | Underperform | $52← $68 |
Earnings History & Surprises
CNCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 23, 2026 | — | — | — | — |
Q1 2026 | Feb 3, 2026 | $-1.25 | — | — | — |
Q4 2025 | Oct 29, 2025 | $-0.21 | $0.50 | +338.1% | ✓ BEAT |
Q3 2025 | Jul 25, 2025 | $0.11 | $-0.16 | -243.4% | ✗ MISS |
Q2 2025 | Apr 25, 2025 | $2.52 | $2.90 | +15.1% | ✓ BEAT |
Q1 2025 | Feb 4, 2025 | $0.44 | $0.80 | +81.8% | ✓ BEAT |
Q4 2024 | Oct 25, 2024 | $1.33 | $1.62 | +21.8% | ✓ BEAT |
Q3 2024 | Jul 26, 2024 | $2.07 | $2.42 | +16.9% | ✓ BEAT |
Q2 2024 | Apr 26, 2024 | $2.08 | $2.26 | +8.7% | ✓ BEAT |
Q1 2024 | Feb 6, 2024 | $0.43 | $0.45 | +4.7% | ✓ BEAT |
Q4 2023 | Oct 24, 2023 | $1.58 | $2.00 | +26.6% | ✓ BEAT |
Q3 2023 | Jul 28, 2023 | $2.03 | $2.10 | +3.4% | ✓ BEAT |
Q2 2023 | Apr 25, 2023 | $2.09 | $2.11 | +1.0% | ✓ BEAT |
Q1 2023 | Feb 7, 2023 | $0.87 | $0.86 | -1.1% | ✗ MISS |
Q4 2022 | Oct 25, 2022 | $1.24 | $1.30 | +4.8% | ✓ BEAT |
Q3 2022 | Jul 26, 2022 | $1.73 | $1.77 | +2.3% | ✓ BEAT |
Q2 2022 | Apr 26, 2022 | $1.68 | $1.83 | +8.9% | ✓ BEAT |
Q1 2022 | Feb 8, 2022 | $0.99 | $1.01 | +2.0% | ✓ BEAT |
Q4 2021 | Oct 26, 2021 | $1.25 | $1.26 | +0.8% | ✓ BEAT |
Q3 2021 | Jul 27, 2021 | $1.41 | $1.25 | -11.3% | ✗ MISS |
Latest News
President Trump Says We Could Get Insurance Companies To Cut Prices To Stay In System; I Will Call Meeting Of Insurance Companies To Get Their Price Down; Meeting In Coming Weeks
📈 PositiveShares of healthcare stocks are trading higher amid the Republican healthcare bill failing to win enough votes to advance in the Senate.
📈 PositiveReuters: Some States Operating ACA Marketplaces Say Enrollment Is Significantly Down From Same Period Last Year, California Says ACA Enrollment Down By 33% vs Last Year
📉 NegativeShares of healthcare stocks are trading higher after Politico reported the White House will propose a two-year extension of Obamacare subsidies with new limits on eligibility.
📈 PositivePolitico Reported The White House To Propose A Two-year Extension Of Obamacare Subsidies With New Limits On Eligibility
➖ NeutralBernstein Maintains Outperform on Centene, Raises Price Target to $45
📈 PositiveShares of health insurers are trading higher amid a possible rebound after President Trump recently proposed that healthcare funding should go directly to people. On Monday, the Senate passed its shutdown-ending bill that lacked a provision to extend Obamacare subsidies; however, the Democrats secured a commitment to vote on credits in December.
📈 PositiveWells Fargo Maintains Equal-Weight on Centene, Lowers Price Target to $35
➖ NeutralCentene Reaffirms 2025 Guidance Ahead Of UBS Global Healthcare Conference: FY25 GAAP Forecast Of A Diluted Loss Per Share Not To Exceed $(12.85) And Full Year 2025 Adjusted Diluted EPS Forecast Of At Least $2.00
➖ NeutralShares of healthcare stocks are trading lower after the US Senate approved a deal clearing the path to ending the government shutdown. The deal does not include an extension of expiring Affordable Care Act subsidies
📉 NegativeWatching Health Care Stocks; Traders Circulate Report Saying Speaker Johnson Says Won't Promise A Vote On Health-Care Subsidies
📉 NegativeJP Morgan Maintains Neutral on Centene, Raises Price Target to $38
➖ NeutralBarclays Maintains Equal-Weight on Centene, Raises Price Target to $44
📈 PositiveTD Cowen Maintains Hold on Centene, Raises Price Target to $34
➖ NeutralGoldman Sachs Maintains Sell on Centene, Raises Price Target to $38
➖ NeutralCantor Fitzgerald Maintains Neutral on Centene, Raises Price Target to $41
➖ NeutralTruist Securities Reiterates Buy on Centene, Raises Price Target to $45
📈 PositiveCentene rises on 2025 EPS guidance boost
📈 PositiveUPDATE: Centene Raises FY2025 Adj EPS Guidance from $1.75 to $2.00 vs $1.68 Est
📈 PositiveCentene shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositiveFrequently Asked Questions about CNC
What is CNC's current stock price?
What is the analyst price target for CNC?
What sector is Centene Corporation in?
What is CNC's market cap?
Does CNC pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CNC for comparison